
TeraRecon Collaboration With Avicenna.AI Will Add Two New AI-Based Imaging Interpretation Applications in Pulmonary Embolism and Aortic Dissection to Eureka Software Platform
11-1-23 (by: Scott Gleason) TeraRecon a provider of AI-based advanced visualization software focused on cardiology and neurology, has announced an expanded collaboration with Avicenna.AI, a specialist in medical imaging AI applications. Their partnership aims to offer improved imaging interpretation solutions that enhance patient triage for individuals facing pulmonary embolism (PE) and aortic dissection (AD). Diagnosing and coordinating care for patients dealing with PE and AD can be particularly challenging. Avicenna.AI holds FDA approval for its algorithms, customized for PE and both Type A and Type B AD. The companies will integrate these detection algorithms into the Eureka Clinical AI platform. This integration is designed to simplify the identification of these conditions, empowering multidisciplinary patient care coordination. When a PE or AD is detected, the Eureka Clinical AI platform. The Eureka Clinical AI platform is used my multiple AI software developers for different applications in cardiology and neurology. Furthermore, the aortic module offering will provide access to imaging and workflows that support coordinated care for patients with abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), rupture, stenosis, and transection, alongside the AD algorithm.
The inclusion of these AI-powered workflows via the Eureka Clinical AI platform is expected to significantly reduce the time it takes for a radiologist to diagnose these potentially life-threatening conditions, ultimately leading to faster treatment and improved patient outcomes. TeraRecon currently has 1,900 customers that use its software applications. Eureka Clinical AI, developed by ConcertAI’s TeraRecon, is the leading AI SaaS imaging interpretation and clinical decision augmentation solutions and is the most widely deployed platform in the industry.
Dan McSweeney, President of TeraRecon, expressed their commitment to expanding the Eureka Clinical AI ecosystem with impactful AI solutions that support clinicians and care providers. He highlighted the crucial role Avicenna’s solutions play in broadening access to essential triage capabilities through their scalable Eureka Clinical AI platform.